MétaCan
Menu
← Back to cohort
Record W7162025306 · doi:10.82308/19536

Randomized controlled trial of human papillomavirus testing versus Pap cytology for primary screening of cervical cancer precursors

2007· dissertation· en· W7162025306 on OpenAlexaboutno aff
Marie-Hélène. Mayrand

Bibliographic record

Venuenot available
Typedissertation
Languageen
FieldMedicine
TopicCervical Cancer and HPV Research
Canadian institutionsnot available
Fundersnot available
KeywordsColposcopyPapanicolaou stainCytologyCervical intraepithelial neoplasiaRandomized controlled trialCervical cancerPapanicolaou TestPap test

Abstract

fetched live from OpenAlex

Introduction. Despite its successful history in cervical cancer screening, the false negative rate of Papanicolaou (Pap) cytology is an important concern. Testing for DNA of oncogenic human papillomaviruses (HPV) could circumvent this limitation. The present thesis reports the results of the first screening round of the Canadian Cervical Cancer Screening Trial (CCCaST). Objectives. To compare the performance (sensitivity, specificity, positive and negative predictive values) of HPV testing vs. Pap cytology in the detection of cervical cancers and their high-grade precursors and explore the impact of sampling order, test thresholds and combinations, and patient characteristics and laboratory on test performance. Methods. CCCaST is a randomized controlled trial (RCT) that compares HPV testing with Hybrid Capture 2 and conventional Pap cytology as screening interventions to identify high-grade cervical intraepithelial neoplasia among women aged 30-69 years in Montreal, Quebec, and St. John's, Newfoundland. Women with an abnormal Pap (≥atypical squamous cells) or a positive HPV (≥1 pg/ml of high-risk HPV DNA) underwent colposcopy and biopsy, as did a random sample of women with negative tests. Performance estimates were corrected for verification bias. Logistic regression modelling was used to investigate the importance of spectrum effect due to selected patient and laboratory characteristics. Results. 10,154 women were randomized. The sensitivity of HPV testing was substantially higher (94.6%, 95% confidence interval [CI]: 84.2-100) than that of Pap cytology (55.4%, 95%CI: 33.6-77.2), albeit with a slightly lower specificity (Pap: 96.8%, 95%CI: 96.3-97.3; HPV: (94.1%, 95%CI: 93.4-94.8). Performance was unaffected by which test was performed first. Use of both tests in parallel was 100% sensitive and 92.5% specific. Triage algorithms for Pap or HPV resulted in fewer referrals but were less sensitive. Spectrum effect analysis revealed that women over 40 reporting no new sexual partner in the last year would benefit from the higher sensitivity of HPV testing, while benefiting from comparable specificity to that of Pap cytology. Conclusion. The first RCT of HPV versus Pap testing for primary screening in North America demonstrates the greater sensitivity of HPV compared to cytology. Our study supports a paradigm change in cervical cancer screening.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.009
metaresearch head score (Gemma)0.018
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.025
Threshold uncertainty score0.051

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0090.018
Meta-epidemiology (narrow)0.0030.001
Meta-epidemiology (broad)0.0060.004
Bibliometrics0.0010.001
Science and technology studies0.0010.002
Scholarly communication0.0020.001
Open science0.0020.001
Research integrity0.0040.004
Insufficient payload (model declined to judge)0.0140.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.093
GPT teacher head0.448
Teacher spread0.356 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designRandomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2007
Admission routes1
Has abstractyes

Explore more

Same topicCervical Cancer and HPV Research→French-language works237,207→